Following the work of Margolis (1957 Margolis ( , 1958 and others, it has been appreciated that a large part of the clotting time of blood is taken up in activating the contact system (factors XII and XI), and also that uncontrolled conditions during this stage account for much experimental variability (Hardisty and Macpherson, 1962) . A preliminary incubation of the plasma with kaolin conveniently shortens the partial thromboplastin time, and the variability is more than correspondingly reduced. Proctor and Rapaport (1961) 
deviation of ± 3 0 sec., giving a coefficient of variation of 7 %.
It was not clear whether the smaller range of normal variation observed by Proctor and Rapaport was mainly due to a greater homogeneity of their tested population or to a lower experimental error of their kaolin test (since the effects of subject and experimental variation would be additive). It was therefore interesting to compare experimental and normal subject variation with a kaolin-modified test. We also wished to establish a working limit for the normal variation appropriate to the difference between test times obtained from a patient and a single control subject, on the lines previously suggested for the prothrombin time (Ingram and Armitage, 1959) . Particular attention was given to the problem of the diagnosis of 'mild haemophilia'.
METHODS
Blood was taken into one ninth of its volume of 3-2% sodium citrate solution in polystyrene containers, and plasma obtained by centrifugation.
THE TEST For the test, 0-1 ml. of plasma is mixed with an equal volume of a suspension of light kaolin, I mg./ml., in aminotris(hydroxymethyl)methane buffer, 0-05 M,pH 7-2 at 37°C. (Gomori, 1946) and incubated for 10 min. at 37°C. in a glass or polystyrene clotting tube. The reaction mixture is then completed by the addition of 0-1 ml. volumes of a suspension of Inosithin' (a soy-bean phospholipid preparation) about 1 mg./ml. and 0 025 M calcium chloride solution, and the clotting time is determined. Other commercial phospholipid sources were investigated by Quick and Geppert (1963) and Fenichel, Baker, and Rose (1964) , and may be used instead of Inosithin, and preliminary tests have suggested that slightly more reproducible results are obtained by adding the phospholipid preparation after the kaolin treatment rather than with the kaolin, as has been previously suggested. Tests can be set up at one-minute or twominute intervals (depending upon the clotting time expected) so that numerous samples may be tested concurrently.
Two replicate readings are obtained from each plasma sample. With the object of eliminating systematic trends related to the passage of time, one replicate reading is obtained in order from each plasma sample, including the control, and then the second replicates are obtained serially in the opposite order (Cox, 1951) . The means of the duplicate readings are taken as the partial thromboplastin times. The differences between duplicate readings provided the measure of experimental error used in the present investigation.
Like any other clotting test, the partial thromboplastin time may be prolonged either because a necessary clotting factor is missing or because the plasma contains an inhibiting substance. tion are rarer than the first, it is not difficult to set up the test so as to detect a prolongation by an inhibitor. When investigating a single patient, it is therefore usually convenient to employ the 10 min. preincubation period in setting up six tests at 60-or 90-sec. intervals in the following order: control, control and patient 50:50, patient, patient, control and patient 50:50, control. If the patient's result is normal, the tests on the mixtures are uninformative; but if the patient's time is prolonged, a near-normal clotting time of the mixture suggests a deficiency in the patient's plasma (made good by the equal volume of normal plasma) whereas a long clotting time of the mixture suggests an inhibitor.
An inactivator of a clotting factor, e.g., an anti-factor VHI, may be demonstrated by progressive prolongation of the partial thromboplastin time when the 50:50 mixture is incubated. In this case the relevant control is the partial thromboplastin time of a freshly made 50:50 mixture of the patient's and the control plasmas which have been incubated separately alongside the incubated mixture. Plasmas from 42 ostensibly healthy adult subjects of both sexes were therefore tested in groups of two to five. In this way they provided 70 different pairs of plasmas where both members of the pair had been tested in the same experiment as described.
The means of the replicate readings from each of the 42 subjects were obtained and ranged from 29-2 to 38-0 sec., about a grand mean of 33-7 sec. The 70 differences between the means of the paired subjects were then calculated, and these yielded a standard error for a single subject of + 3-01 sec. (Appendix, formula 2), corresponding to a coefficient of variation of 8-9 %. From this, the standard error for the difference between mean clotting times from two random subjects (Appendix, formula 3) was found to be ± 4-25 sec., corresponding to a coefficient of variation of 12-6%, of which it has been shown above that experimental error would contribute less than half (4 9 %).
It was thus clear that experimental error was small compared to differences between subjects, so that variations in the experimental error among different observers could reasonably be ignored, and the estimate of subject variation accepted for all observers. It was also found that the difference between subjects did not tend to increase in proportion to their mean partial thromboplastin time over the range encountered with normal persons. The results from patients and controls could therefore be compared simply by taking the differences between them, and it was unnecessary to calculate a series of critical differences appropriate to different control results, as had been required for the prothrombin time (Ingram and Armitage, 1959) . It was also found that the results showed no long-term fluctuations over a period of eight months, which suggested that the reagents remained stable.
In the diagnosis of the bleeding disorders, the question asked is whether the patient's partial thromboplastin time is significantly longer than that of the control subject; shorter times than the control are of no consequence in this context. A 'one-sided' significance test is therefore appropriate, and the patient's partial thromboplastin time would significantly exceed the control value at the 5 % probability level if it were longer by 4-25 x 1-65 = 7-0 sec. or more (where 1-65 is the t-table entry for the 10% level on co d.f. for the ordinary two-sided test). The corresponding limit at the 1 % level would be 4-25 x 2-33 =9-9 sec. It is suggested that 7 sec. be taken as the critical difference for ordinary purposes, a difference of 10 sec. or more being clearly abnormal. Now, reference to Fig. 1 Taking the corresponding criteria to those previously adopted, the patient's mean would significantly exceed the control mean in the modified test at the 5 % probability level if it were longer by 4-57 x 1-65 = 7-6 sec. or more. The corresponding limit at the 1 % level would be 4-57 x 2-33 = 10-7 sec. It is suggested that for simplicity 7 sec. is taken as the working critical difference, which is conveniently the same value as that suggested for the unmodified test.
Next it was necessary to consider the difference in factor-VIII concentration represented by a difference in clotting time of 7 sec. at a 1 in 20 dilution of test and control plasmas in haemophilic plasma. Blood was therefore taken from two normal persons known to differ widely in their factor-VIII levels: each plasma was diluted 1 in 10 and 1 in 40 in the same haemophilic plasma, and the means of four replicate clotting times obtained on each plasma at each dilution. From each plasma the difference between mean clotting times at the two dilutions was taken to represent the slope of the dose-response curve at a dilution of 1 in 20 (since the regression of response on log. dose was known to be approximately linear in this region). Despite a 2 4-fold difference in factor-VIII concentration between the two subjects' plasmas, the slopes were almost identical and a common slope was taken. On It is particularly informative to compare the results of the partial thromboplastin and prothrombin times, for if either is normal it may be inferred that an abnormality in the other is unlikely to be due to a defect in the conversion of prothrombin or in the formation of fibrin, and also that the thromboplastic factors required by both tests (factors V and X) are normal. If the partial thromboplastin time alone is abnormal, factors VIII or IX (or possibly XI or XII) are probably reduced, whereas an abnormality of the prothrombin time alone points to a reduction in factor VII.
3 to 5 sec. shorter may be obtained by increasing the kaolin concentration to 5 mg./ml. in the reagent suspension. Since, in the above experiments, the coefficient of variation between persons was not increased by the dilution in haemophilic plasma which prolonged the mean clotting time from 34 to 64 sec., it is unlikely that the coefficient would be much reduced by shortening the mean normal clotting time to about 30 sec. It seems wise to apply a maximal contact stimulus, and if the higher concentration of kaolin is therefore used, it is probable that our values for the 'normal range' of the test can still be used. 
